Treatment Outcomes and Toxicities for Patients with Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab

被引：0
|
作者：
Pakeerathan, Veenaa [1 ]
Babu, Hari [1 ]
Andelkovic, Vladimir [1 ]
机构：
[1] Princess Alexandra Hosp, Woolloongabba, Qld, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：54 / 55
页数：2
相关论文
共 50 条
  • [31] Evaluation of Treatment Outcomes Using dNLR and GNRI in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma
    Naganuma, Atsushi
    Kakizaki, Satoru
    Hiraoka, Atsushi
    Tada, Toshifumi
    Hatanaka, Takeshi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    Toyoda, Hidenori
    Ogawa, Chikara
    Nishikawa, Hiroki
    Nishimura, Takashi
    Kawata, Kazuhito
    Kosaka, Hisashi
    Hirooka, Masashi
    Yata, Yutaka
    Ohama, Hideko
    Kuroda, Hidekatsu
    Matono, Tomomitsu
    Aoki, Tomoko
    Kanayama, Yuki
    Tanaka, Kazunari
    Tada, Fujimasa
    Nouso, Kazuhiro
    Morishita, Asahiro
    Tsutsui, Akemi
    Nagano, Takuya
    Itokawa, Norio
    Okubo, Tomomi
    Arai, Taeang
    Imai, Michitaka
    Nakamura, Shinichiro
    Enomoto, Hirayuki
    Kaibori, Masaki
    Hiasa, Yoichi
    Kudo, Masatoshi
    Kumada, Takashi
    CANCER MEDICINE, 2025, 14 (02):
  • [32] Risk of Variceal Bleeding in Patients Receiving Atezolizumab-Bevacizumab Treatment for Hepatocellular Carcinoma
    Park, Kanghee
    Lee, Hye Won
    Kim, Euichang
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Yoo, Changhoon
    Ryoo, Baek-Yeol
    Han, Seungbong
    Choi, Jonggi
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025,
  • [33] Prediction of treatment response using contrast-enhanced ultrasonography in patients treated with Atezolizumab and Bevacizumab for unresectable hepatocellular carcinoma
    Takada, Hitomi
    Maekawa, Shinya
    Enomoto, Nobuyuki
    JOURNAL OF HEPATOLOGY, 2022, 77 : S387 - S387
  • [34] Remaining Issues Related to Serum Cytokines in Patients with Unresectable Hepatocellular Carcinoma Treated by Atezolizumab plus Bevacizumab Combination Treatment
    Nagai, Hidenari
    Mukozu, Takanori
    Matsui, Teppei
    Mohri, Kunihide
    Nagumo, Hideki
    Yoshimine, Naoyuki
    Kobayashi, Kojiro
    Ogino, Yu
    Daido, Yasuko
    Wakui, Noritaka
    Momiyama, Koichi
    Matsuda, Takahisa
    Igarashi, Yoshinori
    Higai, Koji
    ONCOLOGY, 2024, 102 (10) : 828 - 840
  • [35] Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: A real-world, multicenter study
    Rossari, F.
    Tada, T.
    Shimose, S.
    Kudo, M.
    Yoo, C.
    Cheon, J.
    Finkelmeier, F.
    Lim, H. Y.
    Presa, J.
    Masi, G.
    Bergamo, F.
    Amadeo, E.
    Vitiello, F.
    Foti, S.
    Persano, M.
    Piscaglia, F.
    Scartozzi, M.
    Cascinu, S.
    Rimini, M.
    Gardini, A. Casadei
    ANNALS OF ONCOLOGY, 2023, 34 : S1547 - S1547
  • [36] Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a real-world, multicenter study
    Rossari, Federico
    Tada, Toshifumi
    Suda, Goki
    Shimose, Shigeo
    Kudo, Masatoshi
    Yoo, Changhoon
    Cheon, Jaekyung
    Finkelmeier, Fabian
    Lim, Ho Yeong
    Presa, Jose
    Masi, Gianluca
    Bergamo, Francesca
    Amadeo, Elisabeth
    Vitiello, Francesco
    Kumada, Takashi
    Sakamoto, Naoya
    Iwamoto, Hideki
    Aoki, Tomoko
    Chon, Hong Jae
    Himmelsbach, Vera
    Iavarone, Massimo
    Cabibbo, Giuseppe
    Montes, Margarida
    Foschi, Francesco Giuseppe
    Vivaldi, Caterina
    Solda, Caterina
    Sho, Takuya
    Niizeki, Takashi
    Nishida, Naoshi
    Steup, Christoph
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    Ochi, Hironori
    Yasuda, Satoshi
    Toyoda, Hidenori
    Ogawa, Chikara
    Nishimura, Takashi
    Hatanaka, Takeshi
    Kakizaki, Satoru
    Shimada, Noritomo
    Kawata, Kazuhito
    Hiraoka, Atsushi
    LIVER CANCER, 2024, 13 (05) : 522 - 536
  • [37] Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications
    Lee, Cha Len
    Freeman, Mark
    Burak, Kelly W.
    Moffat, Gordon T.
    O'Donnell, Conor D. J.
    Ding, Philip Q.
    Lyubetska, Hanna
    Meyers, Brandon M.
    Gordon, Vallerie
    Kosyachkova, Ekaterina
    Bucur, Roxana
    Cheung, Winson Y.
    Knox, Jennifer J.
    Tam, Vincent C.
    CANCERS, 2024, 16 (16)
  • [38] Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab
    Sang, Yun Beom
    Lee, Chaeryoung
    Kim, Seul-Gi
    Lee, Boyoung
    Kang, Beodeul
    Kim, Chan
    Chon, Hong Jae
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [39] Rechallenge With Lenvatinib After Atezolizumab Plus Bevacizumab Treatment for Hepatocellular Carcinoma
    Komatsu, Shohei
    Yano, Yoshihiko
    Kido, Masahiro
    Kuramitsu, Kaori
    Gon, Hidetoshi
    Fukushima, Kenji
    Urade, Takeshi
    So, Shinichi
    Yamamoto, Atsushi
    Goto, Tadahiro
    Yanagimoto, Hiroaki
    Toyama, Hirochika
    Ueda, Yoshihide
    Kodama, Yuzo
    Fukumoto, Takumi
    ANTICANCER RESEARCH, 2022, 42 (11) : 5479 - 5486
  • [40] Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
    Finn, Richard S.
    Qin, Shukui
    Ikeda, Masafumi
    Galle, Peter R.
    Ducreux, Michel
    Kim, Tae-You
    Kudo, Masatoshi
    Breder, Valeriy
    Merle, Philippe
    Kaseb, Ahmed O.
    Li, Daneng
    Verret, Wendy
    Xu, Derek-Zhen
    Hernandez, Sairy
    Liu, Juan
    Huang, Chen
    Mulla, Sohail
    Wang, Yulei
    Lim, Ho Yeong
    Zhu, Andrew X.
    Cheng, Ann-Lii
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20): : 1894 - 1905
12345